Postoperative Treatment With Angiotensin-Converting Enzyme Inhibitors in Patients With Preoperative Reduced Left Ventricular Systolic Function

Left Ventricular ◽

Postoperative Treatment ◽

Converting Enzyme ◽

Postoperative Treatment With Angiotensin-Converting Enzyme Inhibitors in Patients With Preoperative Reduced Left Ventricular Systolic Function

Survey of Anesthesiology ◽

10.1097/01.sa.0000318704.03475.da ◽

2009 ◽

Vol 53 (1) ◽

pp. 3-4

Author(s):

&NA;

Keyword(s):

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Systolic Function ◽

Left Ventricular ◽

Postoperative Treatment ◽

Converting Enzyme ◽

Use of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function

American Heart Journal ◽

10.1016/s0002-8703(97)70123-6 ◽

1997 ◽

Vol 134 (2) ◽

pp. 188-195 ◽

Cited By ~ 65

Author(s):

Edward F. Philbin ◽

Thomas A. Rocco

Keyword(s):

Heart Failure ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Systolic Function ◽

Left Ventricular ◽

Converting Enzyme ◽

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

The Lancet ◽

10.1016/s0140-6736(03)14283-3 ◽

2003 ◽

Vol 362 (9386) ◽

pp. 767-771 ◽

Cited By ~ 1352

Author(s):

John JV McMurray ◽

Jan Östergren ◽

Karl Swedberg ◽

Christopher B Granger ◽

Peter Held ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Enzyme Inhibitors ◽

Systolic Function ◽

Left Ventricular ◽

Converting Enzyme ◽

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

The Lancet ◽

10.1016/s0140-6736(03)14284-5 ◽

2003 ◽

Vol 362 (9386) ◽

pp. 772-776 ◽

Cited By ~ 1192

Author(s):

Christopher B Granger ◽

John JV McMurray ◽

Salim Yusuf ◽

Peter Held ◽

Eric L Michelson ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Enzyme Inhibitors ◽

Systolic Function ◽

Left Ventricular ◽

Converting Enzyme ◽

Faculty Opinions recommendation of Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1097933.556071 ◽

2008 ◽

Author(s):

Mariell Jessup

Keyword(s):

Heart Failure ◽

Enzyme Inhibitors ◽

Systolic Function ◽

Beta Blockers ◽

Left Ventricular ◽

Converting Enzyme ◽

Effect of Statins, Angiotensin-Converting Enzyme Inhibitors, and Beta Blockers on Survival in Patients ≥65 Years of Age With Heart Failure and Preserved Left Ventricular Systolic Function

The American Journal of Cardiology ◽

10.1016/j.amjcard.2007.08.050 ◽

2008 ◽

Vol 101 (2) ◽

pp. 217-222 ◽

Cited By ~ 52

Author(s):

Rahman Shah ◽

Yung Wang ◽

JoAnne M. Foody

Keyword(s):

Heart Failure ◽

Enzyme Inhibitors ◽

Systolic Function ◽

Beta Blockers ◽

Left Ventricular ◽

Converting Enzyme ◽

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting enzyme inhibitors: the CHARM-alternative trial

ACC Current Journal Review ◽

10.1016/j.accreview.2003.10.014 ◽

2004 ◽

Vol 13 (1) ◽

pp. 37

Author(s):

C.B Granger ◽

J.J McMurray ◽

S Yusuf

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Enzyme Inhibitors ◽

Systolic Function ◽

Left Ventricular ◽

Converting Enzyme ◽

Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular Systolic Function

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2005.11.073 ◽

2006 ◽

Vol 47 (8) ◽

pp. 1576-1583 ◽

Cited By ~ 102

Author(s):

Mouaz H. Al-Mallah ◽

Imad M. Tleyjeh ◽

Ahmed A. Abdel-Latif ◽

W. Douglas Weaver

Keyword(s):

Coronary Artery Disease ◽

Enzyme Inhibitors ◽

Systolic Function ◽

Left Ventricular ◽

Converting Enzyme ◽

Converting Enzyme Inhibitors ◽

Artery Disease

Faculty Opinions recommendation of Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1097933.572557 ◽

2008 ◽

Author(s):

Melvin Cheitlin

Keyword(s):

Heart Failure ◽

Enzyme Inhibitors ◽

Systolic Function ◽

Beta Blockers ◽

Left Ventricular ◽

Converting Enzyme ◽

Effect of Statins, Angiotensin-Converting Enzyme Inhibitors, and Beta Blockers on Survival in Patients ≥65 Years of Age With Heart Failure and Preserved Left Ventricular Systolic Function

Yearbook of Cardiology ◽

10.1016/s0145-4145(08)79346-8 ◽

2009 ◽

Vol 2009 ◽

pp. 368-370

Author(s):

M.D. Cheitlin

Keyword(s):

Heart Failure ◽

Enzyme Inhibitors ◽

Systolic Function ◽

Beta Blockers ◽

Left Ventricular ◽

Converting Enzyme ◽